Research / ESCA / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-24-010066 General Corporate
Debt relative to revenue 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
19.31% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.79% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
18.34% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-16.00% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
35.08% · OPTIONAL · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.76% · CORE · VALID
R&D intensity 100th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.18% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.76% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 46 states Self-history eligible
Mar 19, 2022 7/7 normalized Level 3 Jul 9, 2022 7/7 normalized Level 3 Oct 1, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 30.24%
Current 19.31%
Delta -10.93% Capex Intensity Increased
Previous 0.67%
Current 0.79%
Delta 0.12% Cash Generation Increased
Previous 2.72%
Current 18.34%
Delta 15.62% Growth Decreased
Previous 0.05%
Current -16.00%
Delta -16.04% Inventory Pressure Decreased
Previous 38.84%
Current 35.08%
Delta -3.76% Profitability Decreased
Previous 8.39%
Current 6.76%
Delta -1.63% R And D Intensity Increased
Previous 0.86%
Current 1.18%
Delta 0.32% Sbc Intensity Increased
Previous 0.63%
Current 0.76%
Delta 0.13% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.